Skip to main content
. Author manuscript; available in PMC: 2012 Feb 13.
Published in final edited form as: J Neuroimmunol. 2011 Nov 12;240-241:129–136. doi: 10.1016/j.jneuroim.2011.10.009

Fig. 1.

Fig. 1

Dose-dependent phage-IPCR demonstrates peptide binding specificity to persistent IgG in the longitudinal CSF. Longitudinally obtained MS CSF and control pre-immune human IgG (50 μl at IgG concentration of 1 μl/ml) were coated in duplicate onto wells of protein A-plates before addition of the corresponding phage peptides (at serial 10-fold dilutions starting with 107 pfu) to each well. Bound phage were lysed and the DNA was amplified by real-time PCR. Peptide binding specificity was determined based on Ct values. Compared to control human IgG, phage peptides bound specifically to the paired CSF IgG with equal affinity in a dose-dependent manner. Experiments were repeated at least once. Error bars represent SD. A–E, Phage peptide binding specificity in patients 1–5, respectively. Data represent at least three independent experiments.